MEDIMAPI
ActiveSummary
MEDIMAPI has been active since 2016 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €2.16M and a net result of €362k. Equity is growing by ~21.7% per year across the filed fiscal years. Its solvency ranks better than 95% of 19913 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2024
Axes · tick = 2023
Profitability89▲+5
Solvency100=
Growth78▲+26
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €200k at 30 days acceptable
Liquidity ample (current ratio 37.16 against 47.16 in 2023; short-term debt: 2.7% and cash: 65.1% of total assets), and 2.7% of the assets are financed with debt.
Credit check for your own amount and term
Signals
Three signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2024Solvency, return and age of the figures
Solvency
97.3%
Return on assets
16.3%
Age of the figures
21 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 29-08-2025, 29 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 8 filingsDeviation from the deadline
2024
29 d late
2023
on the day
2022
2 d early
2021
3 d late
2020
1 d early
2019
29 d late
2018
8 d late
← before the deadline
after the deadline →
Checked, nothing found (1)
Financials · fiscal year 2024, micro schema
Equity
€2.16M▲ 20.1%
2023 · €1.80M
2018: €611klowest in 7 years
2019: €865k▲ +41.7% vs 2018
2020: €1.14M▲ +31.5% vs 2019
2021: €1.17M▲ +3.0% vs 2020
2022: €1.57M▲ +33.9% vs 2021
2023: €1.80M▲ +14.8% vs 2022
2024: €2.16M▲ +20.1% vs 2023highest in 7 years
2018 → 2024
Total assets
€2.22M▲ 20.8%
2023 · €1.84M
2018: €962klowest in 7 years
2019: €981k▲ +2.0% vs 2018
2020: €1.27M▲ +29.5% vs 2019
2021: €1.21M▼ -4.4% vs 2020
2022: €1.62M▲ +33.5% vs 2021
2023: €1.84M▲ +13.5% vs 2022
2024: €2.22M▲ +20.8% vs 2023highest in 7 years
2018 → 2024
Net result
€362k▲ 56.4%
2023 · €231k
2018: €254k
2019: €255k▲ +0.1% vs 2018
2020: €272k▲ +6.9% vs 2019
2021: €370k▲ +36.0% vs 2020
2022: €397k▲ +7.2% vs 2021highest in 7 years
2023: €231k▼ -41.7% vs 2022lowest in 7 years
2024: €362k▲ +56.4% vs 2023
2018 → 2024
Working capital
€2.14M▲ 20.4%
2023 · €1.78M
2018: €610klowest in 7 years
2019: €865k▲ +41.8% vs 2018
2020: €1.14M▲ +31.2% vs 2019
2021: €1.17M▲ +3.1% vs 2020
2022: €1.55M▲ +32.3% vs 2021
2023: €1.78M▲ +15.0% vs 2022
2024: €2.14M▲ +20.4% vs 2023highest in 7 years
2018 → 2024
Trend over the years
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202220232024Trend
Equity€1.14M-€1.17M▲ 3.0%€1.57M▲ 33.9%€1.80M▲ 14.8%€2.16M▲ 20.1%
2020: €1.14Mlowest in 5 years
2021: €1.17M▲ +3.0% vs 2020
2022: €1.57M▲ +33.9% vs 2021
2023: €1.80M▲ +14.8% vs 2022
2024: €2.16M▲ +20.1% vs 2023highest in 5 years
Operating result€398k-€523k▲ 31.3%€580k▲ 10.8%€338k▼ 41.7%€524k▲ 55.1%
2020: €398k
2021: €523k▲ +31.3% vs 2020
2022: €580k▲ +10.8% vs 2021highest in 5 years
2023: €338k▼ -41.7% vs 2022lowest in 5 years
2024: €524k▲ +55.1% vs 2023
Net result€272k-€370k▲ 36.0%€397k▲ 7.2%€231k▼ 41.7%€362k▲ 56.4%
2020: €272k
2021: €370k▲ +36.0% vs 2020
2022: €397k▲ +7.2% vs 2021highest in 5 years
2023: €231k▼ -41.7% vs 2022lowest in 5 years
2024: €362k▲ +56.4% vs 2023
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2024; 2024 is 55% above 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €2.22M
Fixed assets
€18k ▼ 6.4%
Current assets
€2.20M ▲ 21.1%
Equity and liabilities €2.22M
Equity
€2.16M ▲ 20.1%
Debt
€59k ▲ 52.1%
Debt's share of the balance-sheet total rises from 2.1% to 2.7%. Equity and debt are higher.
Key figures and ratios
EBITDA
€531k▲
2023 · €343k
Cash flow
€369k▲
2023 · €236k
Current ratio
37.16▼
2023 · 47.16
Debt to equity
0.03▲
2023 · 0.02
ROE
16.7%▲
2023 · 12.9%
ROA
16.3%▲
2023 · 12.6%
Interest coverage
403.92▲
2023 · 68.81
Debt ≤ 1 year
€59k▲
2023 · €39k
Income taxes
€178k▲
2023 · €115k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2024 against 2023 · 46 lines
Balance sheet
Code20232024
Assets
Total assets20/58€1.84M€2.22M▲
Fixed assets21/28€20k€18k▼
Tangible fixed assets22/27€20k€17k▼
Plant, machinery and equipment23€13k€9k▼
Furniture and vehicles24€6k€9k▲
Financial fixed assets28-€1k
Current assets29/58€1.82M€2.20M▲
Amounts receivable within one year40/41€74k€90k▲
Trade receivables40-€209
Other amounts receivable41€74k€90k▲
Current investments50/53€768k€634k▼
Cash at bank and in hand54/58€834k€1.45M▲
Deferred charges and accrued income490/1€144k€33k▼
Equity and liabilities
Total equity and liabilities10/49€1.84M€2.22M▲
Equity10/15€1.80M€2.16M▲
Contributions10/11€19k€19k=
Reserves13€1.78M€2.14M▲
Tax-exempt reserves132€105k-
Distributable reserves133€1.68M€2.14M▲
Profit (loss) carried forward14€206€270▲
Amounts payable17/49€39k€59k▲
Amounts payable within one year42/48€39k€59k▲
Financial debts43-€190
Credit institutions430/8-€190
Trade debts44€1k-
Suppliers440/4€1k-
Taxes, remuneration and social security45€37k€59k▲
Taxes450/3€37k€59k▲
Accrued charges and deferred income492/3€400-
Income statement
Code20232024
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€5k€7k▲
Other operating charges640/8€1k€1k▲
Gross operating margin9900€344k€533k▲
Operating profit (loss)9901€338k€524k▲
Financial income75/76B€13k€17k▲
Recurring financial income75€13k€17k▲
Financial charges65/66B€5k€1k▼
Recurring financial charges65€5k€1k▼
Profit (loss) for the period before taxes9903€346k€540k▲
Income taxes67/77€115k€178k▲
Profit (loss) for the period9904€231k€362k▲
Transfer from tax-exempt reserves789€89k€105k▲
Profit (loss) for the period to be appropriated9905€320k€467k▲
Appropriation of the result
Profit (loss) to be appropriated9906€321k€467k▲
Profit (loss) brought forward from the previous period14P€126€206▲
Transfer to equity691/2€320k€467k▲
To other reserves6921€320k€467k▲
The notes to these accounts (8 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Accounts by statement
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Non-recurring operating income76A | - | €9k | - | - | - | - |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €41 | €235 | €1k | €5k | €7k | ▲ 44.4% |
| Other operating charges640/8 | - | €1k | €1k | €1k | €1k | ▲ 19.6% |
| Gross operating margin9900 | €400k | €525k | €582k | €344k | €533k | ▲ 54.8% |
| Operating profit (loss)9901 | €398k | €523k | €580k | €338k | €524k | ▲ 55.1% |
| Financial income75/76B | - | €826 | €4k | €13k | €17k | ▲ 25.8% |
| Recurring financial income75 | €206 | €826 | €4k | €13k | €17k | ▲ 25.8% |
| Financial charges65/66B | - | €775 | €8k | €5k | €1k | ▼ 73.6% |
| Recurring financial charges65 | €272 | €775 | €8k | €5k | €1k | ▼ 73.6% |
| Profit (loss) for the period before taxes9903 | €398k | €523k | €575k | €346k | €540k | ▲ 55.8% |
| Income taxes67/77 | €126k | €153k | €178k | €115k | €178k | ▲ 54.6% |
| Profit (loss) for the period9904 | €272k | €370k | €397k | €231k | €362k | ▲ 56.4% |
| Transfer from tax-exempt reserves789 | - | - | - | €89k | €105k | ▲ 18.3% |
| Transfer to tax-exempt reserves689 | - | €105k | - | - | - | - |
| Profit (loss) for the period to be appropriated9905 | €183k | €265k | €397k | €320k | €467k | ▲ 45.8% |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €1.27M | €1.21M | €1.62M | €1.84M | €2.22M | ▲ 20.8% |
| Fixed assets21/28 | €2k | €2k | €21k | €20k | €18k | ▼ 6.4% |
| Tangible fixed assets22/27 | €2k | €2k | €21k | €20k | €17k | ▼ 11.5% |
| Plant, machinery and equipment23 | - | - | €13k | €13k | €9k | ▼ 32.4% |
| Furniture and vehicles24 | - | €2k | €8k | €6k | €9k | ▲ 31.3% |
| Financial fixed assets28 | - | - | - | - | €1k | - |
| Current assets29/58 | €1.27M | €1.21M | €1.60M | €1.82M | €2.20M | ▲ 21.1% |
| Amounts receivable within one year40/41 | €35k | €18k | €60k | €74k | €90k | ▲ 21.5% |
| Trade receivables40 | - | €51 | - | - | €209 | - |
| Other amounts receivable41 | - | €18k | €60k | €74k | €90k | ▲ 21.2% |
| Current investments50/53 | - | - | €15k | €768k | €634k | ▼ 17.4% |
| Cash at bank and in hand54/58 | €1.17M | €1.09M | €1.50M | €834k | €1.45M | ▲ 73.4% |
| Deferred charges and accrued income490/1 | - | €102k | €24k | €144k | €33k | ▼ 77.1% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €1.27M | €1.21M | €1.62M | €1.84M | €2.22M | ▲ 20.8% |
| Equity10/15 | €1.14M | €1.17M | €1.57M | €1.80M | €2.16M | ▲ 20.1% |
| Contributions10/11 | - | €19k | €19k | €19k | €19k | = |
| Reserves13 | €783k | €1.15M | €1.55M | €1.78M | €2.14M | ▲ 20.3% |
| Tax-exempt reserves132 | - | €194k | €194k | €105k | - | - |
| Distributable reserves133 | - | €959k | €1.36M | €1.68M | €2.14M | ▲ 27.9% |
| Profit (loss) carried forward14 | €336k | €100 | €126 | €206 | €270 | ▲ 31.5% |
| Amounts payable17/49 | €132k | €42k | €52k | €39k | €59k | ▲ 52.1% |
| Amounts payable within one year42/48 | €132k | €42k | €52k | €39k | €59k | ▲ 53.7% |
| Financial debts43 | - | - | - | - | €190 | - |
| Credit institutions430/8 | - | - | - | - | €190 | - |
| Trade debts44 | €111k | €20 | €5k | €1k | - | - |
| Suppliers440/4 | - | €20 | €5k | €1k | - | - |
| Taxes, remuneration and social security45 | - | €42k | €47k | €37k | €59k | ▲ 59.1% |
| Taxes450/3 | - | €42k | €47k | €37k | €59k | ▲ 59.1% |
| Accrued charges and deferred income492/3 | - | €241 | - | €400 | - | - |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €272k | €370k | €397k | €231k | €362k | ▲ 56.4% |
| + Depreciation and write-downs630 | €41 | €235 | €1k | €5k | €7k | ▲ 44.4% |
| Operating cash flow (approximation) | €272k | €371k | €398k | €236k | €369k | ▲ 56.1% |
| Investment in fixed assets (approximation) | - | €0 | €-20k | €-4k | €-6k | ▼ 41.9% |
| Change in cash | - | €-83k | €410k | €-667k | €612k | ▲ 192% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
2025
29-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 29 days late
2024
31-12
Financial
Equity above €2MEq €2.16M ▲20.1%
7 profitable years in a row build equity to €2.16M.
30-04
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
30-09
Financial
Weakest financial yearnet €231k ▼41.7%
Net result drops to €231k, the lowest in the series; recovery starts the following year.
28-04
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
30-09
Financial
Highest result since 2018net €397k ▲7.2%
Operating result €580k, net result €397k, both a record.
03-05
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 3 days late
2021
30-09
Financial
Liquidity triplescurrent ratio 28.96
Current ratio from 9.58 to 28.96; short-term debt falls from €132k to €42k.
29-04
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
30-09
Financial
Equity above €1MEq €1.14M ▲31.5%
3 profitable years in a row build equity to €1.14M.
29-05
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 29 days late
2019
30-09
Financial
Liquidity triplescurrent ratio 8.50
Current ratio from 2.74 to 8.50; short-term debt falls from €351k to €115k.
08-05
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 8 days late
2018
04-04
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 5 acts read
About the unread acts
We know of 5 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
5 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Kapellen · 1 establishment unit since 2016
Ground area
1.2 ha
Building footprint
1,217 m²
Volume, LiDAR
41,589 m³
2 parcels, Flanders · tallest building 44.3 m, ±13 floors. Linked by address, not a title deed.
1 establishment unit
MEDIMAPI
since 20162.261.327.841
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11051B0369/00E000 | Flanders | 8,919 m² | 1 · 1,000 m² | 44.3 m · 13 fl. |
| 11023I0019/00T008 | Flanders | 3,190 m² | 1 · 217 m² | 9.2 m · 2 fl. |
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Legal Entity Identifier
699400QZC6OTBBWEXF46
Similar companies · same sector, comparable size
DR. F. VERSTREKEN
BE 0871.584.590
Schoten · Eq €2,160,724
Lieve Van Hoovels
BE 0826.373.682
Asse · Eq €2,164,775
Dr. THYWISSEN
BE 0472.413.358
Diepenbeek · Eq €2,156,074
DR. KARL MORIAS
BE 0872.326.542
Destelbergen · Eq €2,169,339
DR INGE VAN HAUTE
BE 0825.964.007
Ellezelles · Eq €2,169,708
Of 16,625 companies in sector 86220 we hold annual accounts for 7,979. 4,462 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded07-01-2016
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
Scores and ratios are computed by Checked and are not a credit decision.